Recap: Monopar Therapeutics Q3 Earnings

Monopar Therapeutics MNPR reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.


Monopar Therapeutics beat estimated earnings by 17.65%, reporting an EPS of $-0.14 versus an estimate of $-0.17.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 5.21% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Monopar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!